Scandinavian ChemoTech: Insider Debt Conversion and Increased Flexibility - Redeye

A directed issue of SEK2.55m, settled via debt offset by insiders, provides some balance sheet relief. The more interesting story is a proposed move toward a more decentralised structure enabling subsidiary-level financing, potentially reducing parent-level dilution going forward. Changes require both AGM and Nasdaq approval.

Länk till analysen i sin helhet: https://www.redeye.se/research/1158909/scandinavian-chemotech-insider-debt-conversion-and-increased-flexibility?utm_source=finwire&utm_medium=RSS